Skip to content
Subscriber Only

J&J Slams Ex-FDA Chief in Male Breast-Growth Case

Updated on

Johnson & Johnson’s lawyers, in a trial over whether the antipsychotic drug Risperdal caused boys to develop abnormal breasts, attacked a former government health regulator as a biased witness with a penchant for finding that drugmakers hide their medicines’ risks.

David Kessler, the former head of the U.S. Food and Drug Administration, has become a “hired gun” for consumers suing drugmakers since he left government service in 1997 and now routinely finds companies fail to adequately warn the public about their products’ risks, Diane Sullivan, one of J&J’s lawyers, said Friday in state court in Philadelphia.